Rivus Pharmaceuticals

Drug Discovery · Charlottesville, VA · Founded 2019 · Privately Held (backing)

Developer of controlled metabolic accelerators designed to improve cardio-metabolic health. Rivus Pharmaceuticals is based in Charlottesville, VA and was founded in 2019. It was valued at $489 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $224 million across 4 recorded rounds; the latest was a $57 million later-stage round in Jan 2025.

PMV mark · valuation
$489.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$224.0M
Last round
Later Stage VC
Jan 2025

Who backs Rivus Pharmaceuticals?

6 investors
InvestorType
RA Capital ManagementAsset manager
Longitude CapitalVenture capital
Bain Capital Life SciencesVenture capital
BB Biotech—
Medicxi—
RxCelerate—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Rivus Pharmaceuticals investors

6 investors are on record for Rivus Pharmaceuticals, including RA Capital Management, Longitude Capital, Bain Capital Life Sciences and BB Biotech. The later-stage round in Jan 2025 drew 7 investors.

Free account
More of Rivus Pharmaceuticals with a free account
  • ·Watch Rivus Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Rivus Pharmaceuticals in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View